Genbauffe Aline

GIGA Cancer - Metastases Research Laboratory

Département des sciences biomédicales et précliniques > GIGA

Biologie dans le domaine des sc. médicales et biomédicales

See author's contact details

Main Referenced Co-authors

Journe, Fabrice (4)

Mukeba-Harchies, Léa (4)

Soumoy, Laura (4)

Bellahcene, Akeila (3)

Laverdeur, Emilie (3)

Main Referenced Keywords

Animals (2); Humans (2); Melanoma (2); Antineoplastic Agents (1); Antineoplastic Agents/pharmacology (1);

Main Referenced Disciplines

Oncology (7)

Publications (total 7)

Search in publications

The most downloaded

39 downloads

Genbauffe, A., Soumoy, L., Mukeba-Harchies, L., Colet, J.-M., & Journe, F. (October 2024). Bufalin inhibits c-MYC/eIF4A loop and B-oxidation enzyme translation, fighting melanoma resistance to targeted therapies [Poster presentation]. BACR, Bruxelles, Belgium. https://hdl.handle.net/2268/344026

The most cited

12 citations (Scopus®)

Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G., Saussez, S., & Journe, F. (04 January 2024). ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. Cancer Cell International, 24 (1), 8. doi:10.1186/s12935-023-03196-y https://hdl.handle.net/2268/344024